Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4.07x is 77% below its 5-year average of -2.30x, around the middle of its 5-year range (-6.75x–0.01x).
32.98% below its 12-month average of -3.06x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -2.14x.
INTEREST COVERAGE RATIO
-4.07x
INTEREST COVERAGE RATIO AVG TTM
-3.06x
INTEREST COVERAGE RATIO AVG 3Y
-2.40x
INTEREST COVERAGE RATIO AVG 5Y
-2.30x
INTEREST COVERAGE RATIO AVG 10Y
-2.85x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-32.98%
CURRENT VS 3Y AVG
-69.77%
CURRENT VS 5Y AVG
-76.82%
CURRENT VS 10Y AVG
-43.03%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 457 covered companies
CURRENT VS SECTOR MEDIAN
+27.84%
vs the sector median at left
Aquestive Therapeutics, Inc.
Market Cap
$574.01M
Interest Coverage Ratio
-4.07x
TTM Avg
-3.06x
3Y Avg
-2.40x
5Y Avg
-2.30x
Market Cap
$568.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$566.38M
Interest Coverage Ratio
53.97x
TTM Avg
53.97x
3Y Avg
53.97x
5Y Avg
53.97x
Market Cap
$560.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$587.80M
Interest Coverage Ratio
-4.84x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$547.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$593.40M
Interest Coverage Ratio
-1214.61x
TTM Avg
176.24x
3Y Avg
176.24x
5Y Avg
176.24x
Market Cap
$550.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$552.40M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $574.01M | -4.07x | -3.06x | -2.40x | -2.30x |
| CytomX Therapeutics, Inc. (CTMX)vs › | $568.20M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $566.38M | 53.97x | 53.97x | 53.97x | 53.97x |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $587.80M | -4.84x | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $547.18M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.40M | -1214.61x | 176.24x | 176.24x | 176.24x |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $550.11M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $552.40M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.01M | 3.63x | 3.22x | 13.13x | 10.34x |
Interest Coverage
-4.1x
Debt/Equity
N/A
Current Ratio
7.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2.14x |
| 2026-03-31 | -1.07x |
| 2025-12-31 | -6.75x |
| 2025-09-30 | -2.69x |
| 2025-06-30 | -2.66x |
| 2025-03-31 | -4.53x |
| 2024-12-31 | -3.21x |
| 2024-09-30 | -1.97x |
| 2024-06-30 | 0.01x |
| 2024-03-31 | -2.13x |
| 2023-12-31 | -1.21x |
| 2023-09-30 | -1.81x |
| 2023-06-30 | -2.95x |
| 2023-03-31 | -3.10x |
| 2022-12-31 | -6.29x |
| 2022-09-30 | -2.40x |
| 2022-06-30 | -3.57x |
| 2022-03-31 | -2.80x |
| 2021-12-31 | -3.25x |
| 2021-09-30 | -1.21x |
| 2021-06-30 | -1.05x |
| 2021-03-31 | -1.39x |
| 2020-12-31 | -3.31x |
| 2020-09-30 | -4.96x |
| 2020-06-30 | 0.14x |
| 2020-03-31 | -5.00x |
| 2019-12-31 | -3.53x |
| 2019-09-30 | -4.15x |
| 2019-06-30 | -9.65x |
| 2019-03-31 | -6.79x |
| 2018-12-31 | -6.49x |
| 2018-09-30 | -4.76x |
| 2018-06-30 | -16.96x |
| 2018-03-31 | 2.75x |
| 2017-12-31 | -3.68x |
| 2017-09-30 | 5.29x |
| 2017-06-30 | -2.08x |
| 2017-03-31 | 0.43x |
